Flagship Harbor Advisors’s Array Biopharma Inc ARRY Stock Holding History

Flagship Harbor Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-213	Closed	-$9K	–	2039
2019 Q2	$9K	Buy	213 +153	+255%	+$4.3K	﹤0.01%	1352
2019 Q1	$1K	Hold	60	–	–	﹤0.01%	1818
2018 Q4	$0	Buy	+60	New	+$910	﹤0.01%	2199

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Flagship Harbor Advisors's ARRY Position: Q3 2019 in Review

Flagship Harbor Advisors sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 213 shares — an estimated $9K sold.

Flagship Harbor Advisors first reported a position in ARRY in Q4 2018 and held it in 3 quarters. The position peaked at $9K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Flagship Harbor Advisors reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Flagship Harbor Advisors sold 213 Array Biopharma Inc shares in Q3 2019, an estimated $9K.
Flagship Harbor Advisors first reported a position in Array Biopharma Inc in Q4 2018 and held it in 3 quarters.
Flagship Harbor Advisors's Array Biopharma Inc position peaked at $9K in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Flagship Harbor Advisors's 13F filing for Q3 2019, filed 22 Oct 2019.